Related references
Note: Only part of the references are listed.Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort
Alejandro Sanchez et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Metastatic melanoma cells with BRAF G469A mutation: nab-paclitaxel better than vemurafenib?
Letizia Porcelli et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin TOP2A as marker of response to PLD in ovarian cancer
J. Erriquez et al.
GYNECOLOGIC ONCOLOGY (2015)
Malignant Melanoma of Vulva and Vagina: A Histomorphological Review and Mutation Analysis-A Single-Center Study
Marjan Rouzbahman et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2015)
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas
Michael Krauthammer et al.
NATURE GENETICS (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Management of melanomas of the gynaecological tract
Marielle A. E. Nobbenhuis et al.
CURRENT OPINION IN ONCOLOGY (2014)
NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract-A study of 24 cases from the Netherlands
Adriana C. H. van Engen-van Grunsven et al.
GYNECOLOGIC ONCOLOGY (2014)
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Vulvovaginal Melanomas
Mario M. Leitao et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract
Diane Tseng et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Comparison of molecular abnormalities in vulvar and vaginal melanomas
Sebastian Aulmann et al.
MODERN PATHOLOGY (2014)
Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma
James S. Wilmott et al.
CLINICAL CANCER RESEARCH (2012)
BRAF/NRAS Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
Maria Colombino et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques
Nicola L. Schoenewolf et al.
CASE REPORTS IN ONCOLOGY (2012)
KIT amplification and gene mutations in acral/mucosal melanoma in Korea
Jina Yun et al.
APMIS (2011)
The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures
Yueyao Du et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer
K. Takezawa et al.
BRITISH JOURNAL OF CANCER (2011)
KIT Pathway Alterations in Mucosal Melanomas of the Vulva and Other Sites
Katarina Omholt et al.
CLINICAL CANCER RESEARCH (2011)
KIT as a Therapeutic Target in Metastatic Melanoma
Richard D. Carvajal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Anticancer effects of imatinib via immunostimulation
Laurence Zitvogel et al.
NATURE MEDICINE (2011)
KIT mutations in Russian patients with mucosal melanoma
Svetlana N. Abysheva et al.
MELANOMA RESEARCH (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Primary Malignant Melanoma of the Vagina
Michael Frumovitz et al.
OBSTETRICS AND GYNECOLOGY (2010)
Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure
Despina Handolias et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type
Carlos A. Torres-Cabala et al.
MODERN PATHOLOGY (2009)
Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas
I. Satzger et al.
BRITISH JOURNAL OF CANCER (2008)
KIT Gene Mutations and Copy Number in Melanoma Subtypes
Carol Beadling et al.
CLINICAL CANCER RESEARCH (2008)
Vulvar melanoma - A multivariable analysis of 644 patients
Valerie E. Sugiyama et al.
OBSTETRICS AND GYNECOLOGY (2007)
Somatic activation of KIT in distinct subtypes of melanoma
John A. Curtin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Distinct sets of genetic alterations in melanoma
JA Curtin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs
CW Wong et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Absence of BRAF mutations in UV-protected mucosal melanomas
RH Edwards et al.
JOURNAL OF MEDICAL GENETICS (2004)
Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites
Y Cohen et al.
CLINICAL CANCER RESEARCH (2004)
Analysis of O6-methylguanine-DNA methyltransferase in melanoma tumours in patients treated with dacarbazine-based chemotherapy
S Ma et al.
MELANOMA RESEARCH (2002)
Interpreting epidemiological research:: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1
C Eng et al.
JOURNAL OF MEDICAL GENETICS (2001)
Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later
CF Verschraegen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2001)
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
MR Middleton et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
